Itamar Medica

$8.80
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 3:54 PM EDT today
$0.00 (0.00%) Today

Why Robinhood?

You can buy or sell Itamar Medica and other stocks, options, ETFs, and crypto commission-free!

About ITMR

Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. Read More The WatchPAT diagnoses sleep apnea, which has been proven to be a substantial risk factor in cardiac disease. The EndoPAT diagnoses endothelial malfunction, which is a proven predictor of cardiovascular disease. The company was founded by Yaron Giora , Martin Gerstel, Peretz Lavie, and Daniel Gur on January 15, 1997 and is headquartered in Caesarea, Israel.

Employees
Headquarters
Caesarea, Haifa
Founded
1997
Market Cap
97.97M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.91K
High Today
Low Today
Open Price
Volume
0.00
52 Week High
$14.00
52 Week Low
$8.27

Collections

ITMR Earnings

-$0.13
-$0.09
-$0.04
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 13, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.